Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-29

Clinical Trial Update: Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the Skin

View source ↗

Summary

A completed clinical trial evaluated the safety and potential efficacy of a 5% potassium hydroxide topical solution (Molutrex) in children with Molluscum Contag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Molutrex (potassium hydroxide 5% solution)

Snippet

Sponsor: Laboratoire Dermatologique ACM | Conditions: Molluscum Contagiosum | Status: COMPLETED